CNY:PA:PA-HSBC MSCI China UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 5.537

Change

0.00 (0.00)%

Market Cap

USD 0.62B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.52 (+1.20%)

USD 66.11B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-1.00 (-0.20%)

USD 11.38B
WRD:PA HSBC ETFs Public Limited Compa..

-0.04 (-0.13%)

USD 9.27B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.62 (-0.26%)

USD 7.87B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+1.45 (+0.32%)

USD 7.28B
HHH:PA HSBC ETFs Public Limited Compa..

-0.09 (-0.17%)

USD 6.91B
WLD:PA Lyxor UCITS MSCI World D-EUR

-0.17 (-0.05%)

USD 6.48B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.02 (-0.09%)

USD 5.45B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-0.56 (-0.15%)

USD 4.39B
500U:PA Amundi Index Solutions - Amund..

-0.39 (-0.37%)

USD 4.25B

ETFs Containing CNY:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.50% 59% D- 69% C-
Dividend Return N/A 7% C- 90% A-
Total Return N/A 51% F 38% F
Trailing 12 Months  
Capital Gain -6.49% 10% F 37% F
Dividend Return N/A 19% F 13% F
Total Return N/A 47% F 95% A
Trailing 5 Years  
Capital Gain -20.38% 10% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -20.38% 9% A- 25% F
Average Annual (5 Year Horizon)  
Capital Gain -5.49% 8% B- 21% F
Dividend Return N/A 5% F 50% F
Total Return N/A 19% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) N/A 63% D 46% F
Risk Adjusted Return N/A 49% F 50% F
Market Capitalization 0.62B 74% C 73% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.